Timelo Investment Management Inc. Cognition Therapeutics Inc Transaction History
Timelo Investment Management Inc.
- $172 Million
- Q2 2024
A detailed history of Timelo Investment Management Inc. transactions in Cognition Therapeutics Inc stock. As of the latest transaction made, Timelo Investment Management Inc. holds 361,397 shares of CGTX stock, worth $184,312. This represents 0.35% of its overall portfolio holdings.
Number of Shares
361,397
Previous 480,681
24.82%
Holding current value
$184,312
Previous $874,000
31.46%
% of portfolio
0.35%
Previous 0.34%
Shares
2 transactions
Others Institutions Holding CGTX
# of Institutions
48Shares Held
7.64MCall Options Held
0Put Options Held
0-
Pathstone Family Office, LLC Englewood, NJ2.21MShares$1.12 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.15MShares$585,2520.0% of portfolio
-
Awm Investment Company, Inc. New York, NY650KShares$331,5000.17% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$255,0000.01% of portfolio
-
Aigh Capital Management LLC Baltimore, MD301KShares$153,3900.18% of portfolio
About COGNITION THERAPEUTICS INC
- Ticker CGTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,710,700
- Market Cap $11.6M
- Description
- Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, a sigma-2 receptor antagonist, which is in Phase II clinical tr...